Seminars in Arthritis and Rheumatism
Volume 40, Issue 3 , Pages 222-232, December 2010

A Randomized Trial of Three Psychosocial Treatments for the Symptoms of Rheumatoid Arthritis

  • Arthur J. Barsky, MD

      Affiliations

    • Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • Corresponding Author InformationAddress reprint requests to Arthur J. Barsky, MD, Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115
  • ,
  • David K. Ahern, PhD

      Affiliations

    • Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
  • ,
  • E. John Orav, PhD

      Affiliations

    • Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
  • ,
  • Yvonne Nestoriuc, PhD

      Affiliations

    • Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
  • ,
  • Matthew H. Liang, MD, MPH

      Affiliations

    • Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Marburg, Germany
  • ,
  • Ilana T. Berman, PhD, MA

      Affiliations

    • The University of North Carolina at Chapel, NC
  • ,
  • Joshua R. Kingsbury, MS

      Affiliations

    • University of Illinois at Urbana-Champagne, IL
  • ,
  • Jennifer T. Sy, MS

      Affiliations

    • University of Wyoming, Laramie, WY
  • ,
  • Kathryn G. Wilk, CPNP, MS, NP

      Affiliations

    • The MGH Institute of Health Professions Graduate Nursing Program, Boston, MA

published online 12 July 2010.

Objective

To assess and compare the benefits of 3 psychosocial treatments for rheumatoid arthritis (RA).

Methods

RA patients were randomized to cognitive-behavior therapy (CBT), relaxation response training (RR), or arthritis education (AE). All treatment was conducted in groups. Follow-up occurred immediately after treatment and 6 and 12 months later. Pain, other RA symptoms, role impairment, and psychological distress were assessed with standardized self-report questionnaires. Arthritis severity and activity were assessed with a joint examination, erythrocyte sedimentation rate, grip strength, and walking time. An intent-to-treat analytic strategy was employed. Linear regression was used to establish treatment effect on pain and other RA symptoms, while adjusting for sociodemographic and clinical variables.

Results

One hundred sixty-eight patients were randomized. Pain improved significantly at 12 months in the RR and AE groups and showed a nonsignificant positive trend with CBT. Other RA symptoms improved significantly with CBT and AE and showed a nonsignificant trend with RR. There were no significant differences in the outcomes across the 3 treatment groups. When the results for all 3 groups were aggregated, significant benefits were found for pain, other RA symptoms, self-care activities, and social activities. Effect sizes ranged between 0.26 and 0.35.

Conclusions

These 3 psychosocial treatments were beneficial, with treatment effect sizes in the small to moderate range. The effects appeared immediately after treatment and were generally sustained at long-term follow-up. These benefits were achieved over and above those resulting from medical management. These treatments constitute an effective augmentation to standard medical therapy for RA patients.

Keywords: rheumatoid arthritis, cognitive treatment, symptoms, pain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported by research grant R01 AR 4701401 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This study has been registered with ClinicalTrials.gov and received the identifier NCT00056667.

PII: S0049-0172(10)00052-1

doi:10.1016/j.semarthrit.2010.04.001

Seminars in Arthritis and Rheumatism
Volume 40, Issue 3 , Pages 222-232, December 2010